Lv11
18 积分 2026-05-29 加入
A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy Participants
57分钟前
已完结
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
1小时前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
14天前
已完结
Effects of Tablet Formulation, Food, or Gastric pH on the Bioavailability of Asundexian
20天前
已完结
Hydroxy-safflower yellow A composites: An effective strategy to enhance anti-myocardial ischemia by improving intestinal permeability
26天前
已完结
Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- mice
28天前
已完结
Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?
1个月前
已完结
Stability and degradation of hydroxysafflor yellow A and anhydrosafflor yellow B in the Safflower injection studied by HPLC-DAD-ESI-MSn
1个月前
已完结
Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- mice
1个月前
已完结
Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A
1个月前
已完结
皖公网安备34019202002308
